|
Moving towards a personalised understanding of the nutritional impact of self-expanding metallic stents (SEMS) in gastro-oesophageal cancer: A retrospective case note review of a tertiary referral oncology centre. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Ipsen; Novartis |
|
Travel, Accommodations, Expenses - Roche |
|
|
Stock and Other Ownership Interests - The Christie Clinic LLP |
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pfizer |
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai Europe; Ipsen; Merck Sharp & Dohme; Pfizer; Roche |
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma; Ipsen |
|
|
Research Funding - Amgen (Inst) |
|
|
No Relationships to Disclose |
|
|
Honoraria - BMS; BMS; Servier |
Consulting or Advisory Role - BMS; SERVIER |
|
Travel, Accommodations, Expenses - Ipsen; SERVIER; SERVIER |
|
|
No Relationships to Disclose |